Your saved searches
You have no saved searches
Search 1 filter applied
Notification date | Transaction date | Company | B/S Transaction type | Insider and/or position |
Nb. shares Price Value |
Number of shares | Price | Value | Details |
---|---|---|---|---|---|---|---|---|---|
2025-01-17 | 2025-01-17 |
Marvell Technology Inc
(MRVL)
|
PS Planned sale |
Casper Mark EVP & Chief Legal Officer Officer |
7,755
-100.0%
123.08USD 954,485 |
7,755 -100.0% | 123.08 | USD 954,485 | |
2025-01-17 | 2025-01-17 |
New York City REIT Inc
(NYCI)
|
B Purchase |
SCHORSCH NICHOLAS S Large shareholder |
1,367
+0.1%
9.21USD 12,590 |
1,367 +0.1% | 9.21 | USD 12,590 | |
2025-01-17 | 2025-01-17 |
Adaptimmune Therapeutics PLC
(ADAP)
|
S Sale |
Rawcliffe Adrian Chief Executive Officer Executive Director |
30,601
-40.8%
0.58USD 17,773 |
30,601 -40.8% | 0.58 | USD 17,773 | |
2025-01-17 | 2025-01-17 |
Adaptimmune Therapeutics PLC
(ADAP)
|
S Sale |
Norry Elliot Chief Medical Officer Officer |
5,584
-42.6%
0.58USD 3,243 |
5,584 -42.6% | 0.58 | USD 3,243 | |
2025-01-17 | 2025-01-17 |
Adaptimmune Therapeutics PLC
(ADAP)
|
S Sale |
Lunger John Chief Patient Supply Officer Officer |
5,584
-42.6%
0.58USD 3,243 |
5,584 -42.6% | 0.58 | USD 3,243 | |
2025-01-17 | 2025-01-17 |
Adaptimmune Therapeutics PLC
(ADAP)
|
S Sale |
Bertrand William C JR Chief Operating Officer Officer |
5,584
-42.6%
0.58USD 3,243 |
5,584 -42.6% | 0.58 | USD 3,243 | |
2025-01-17 | 2025-01-17 |
Compass Inc
(COMP)
|
PS Planned sale |
Reffkin Robert L. Chairman and CEO Executive Director |
42,717
-2.1%
6.90USD 294,918 |
42,717 -2.1% | 6.90 | USD 294,918 | |
2025-01-17 | 2025-01-17 |
Yellowstone Acquisition Co
(YSAC)
|
S Sale |
BOSTON OMAHA Corp Large shareholder |
7,861
-0.1%
11.36USD 89,292 |
7,861 -0.1% | 11.36 | USD 89,292 | |
2025-01-17 | 2025-01-17 |
Madrigal Pharmaceuticals Inc
(MDGL)
|
S Sale |
Kelley Shannon T General Counsel Officer |
277
-3.5%
273.41USD 75,735 |
277 -3.5% | 273.41 | USD 75,735 | |
2025-01-17 | 2025-01-17 |
Madrigal Pharmaceuticals Inc
(MDGL)
|
S Sale |
Taub Rebecca Pres., R&D, and CMO Executive Director |
1,689
-0.4%
273.41USD 461,789 |
1,689 -0.4% | 273.41 | USD 461,789 | |
2025-01-17 | 2025-01-17 |
Madrigal Pharmaceuticals Inc
(MDGL)
|
S Sale |
Waltermire Robert E. Senior VP, Chief Pharma Dev. Officer |
442
-8.0%
273.41USD 120,847 |
442 -8.0% | 273.41 | USD 120,847 | |
2025-01-17 | 2025-01-17 |
ON24 Inc
(ONTF)
|
PS Planned sale |
Vattuone Steven Chief Financial Officer Officer |
1,022
-0.2%
6.50USD 6,646 |
1,022 -0.2% | 6.50 | USD 6,646 | |
2025-01-17 | 2025-01-17 |
Tempus AI, Inc.
(TEM)
|
S Sale |
KEYWELL BRADLEY A Large shareholder |
148
-0.0%
35.79USD 5,298 |
148 -0.0% | 35.79 | USD 5,298 | |
2025-01-17 | 2025-01-17 |
Tempus AI, Inc.
(TEM)
|
S Sale |
KEYWELL BRADLEY A Large shareholder |
264,852
-1.7%
35.10USD 9,296,861 |
264,852 -1.7% | 35.10 | USD 9,296,861 | |
2025-01-17 | 2025-01-17 |
AGBA Acquisition Ltd
(AGBA)
|
S Sale |
Diamond Robert E. Jr. Non-Executive Director |
120,000
-12.7%
2.46USD 295,200 |
120,000 -12.7% | 2.46 | USD 295,200 | |
2025-01-17 | 2025-01-17 |
Atlassian Corp
(TEAM)
|
PS Planned sale |
Farquhar Scott Non-Executive Director Large shareholder |
100
-0.0%
258.43USD 25,843 |
100 -0.0% | 258.43 | USD 25,843 | |
2025-01-17 | 2025-01-17 |
Atlassian Corp
(TEAM)
|
PS Planned sale |
Farquhar Scott Non-Executive Director Large shareholder |
2,898
-0.7%
253.05USD 733,331 |
2,898 -0.7% | 253.05 | USD 733,331 | |
2025-01-17 | 2025-01-17 |
Atlassian Corp
(TEAM)
|
PS Planned sale |
Farquhar Scott Non-Executive Director Large shareholder |
1,756
-0.4%
254.00USD 446,019 |
1,756 -0.4% | 254.00 | USD 446,019 | |
2025-01-17 | 2025-01-17 |
Atlassian Corp
(TEAM)
|
PS Planned sale |
Farquhar Scott Non-Executive Director Large shareholder |
150
-0.0%
254.85USD 38,228 |
150 -0.0% | 254.85 | USD 38,228 | |
2025-01-17 | 2025-01-17 |
Atlassian Corp
(TEAM)
|
PS Planned sale |
Farquhar Scott Non-Executive Director Large shareholder |
3,044
-0.8%
252.14USD 767,521 |
3,044 -0.8% | 252.14 | USD 767,521 | |
2025-01-17 | 2025-01-17 |
Atlassian Corp
(TEAM)
|
PS Planned sale |
Cannon-Brookes Michael CEO, Co-Founder Executive Director Large shareholder |
3,044
-0.8%
252.14USD 767,521 |
3,044 -0.8% | 252.14 | USD 767,521 | |
2025-01-17 | 2025-01-17 |
Atlassian Corp
(TEAM)
|
PS Planned sale |
Cannon-Brookes Michael CEO, Co-Founder Executive Director Large shareholder |
2,897
-0.7%
253.05USD 733,078 |
2,897 -0.7% | 253.05 | USD 733,078 | |
2025-01-17 | 2025-01-17 |
Atlassian Corp
(TEAM)
|
PS Planned sale |
Cannon-Brookes Michael CEO, Co-Founder Executive Director Large shareholder |
1,757
-0.4%
254.00USD 446,273 |
1,757 -0.4% | 254.00 | USD 446,273 | |
2025-01-17 | 2025-01-17 |
Atlassian Corp
(TEAM)
|
PS Planned sale |
Cannon-Brookes Michael CEO, Co-Founder Executive Director Large shareholder |
150
-0.0%
254.85USD 38,228 |
150 -0.0% | 254.85 | USD 38,228 | |
2025-01-17 | 2025-01-17 |
Atlassian Corp
(TEAM)
|
PS Planned sale |
Cannon-Brookes Michael CEO, Co-Founder Executive Director Large shareholder |
100
-0.0%
258.43USD 25,843 |
100 -0.0% | 258.43 | USD 25,843 | |
2025-01-17 | 2025-01-17 |
Frontier Group Holdings Inc
(ULCC)
|
PS Planned sale |
Biffle Barry CEO Executive Director |
273,000
-25.1%
8.44USD 2,304,120 |
273,000 -25.1% | 8.44 | USD 2,304,120 | |
2025-01-17 | 2025-01-17 |
Atlassian Corp
(TEAM)
|
PS Planned sale |
BHARADWAJ ANUTTHARA President Officer |
1,520
-0.7%
259.85USD 394,972 |
1,520 -0.7% | 259.85 | USD 394,972 | |
2025-01-17 | 2025-01-17 |
Pro-Dex Inc
(PDEX)
|
PS Planned sale |
CABILLOT RAYMOND E Non-Executive Director Large shareholder |
4,013
-1.2%
45.18USD 181,307 |
4,013 -1.2% | 45.18 | USD 181,307 | |
2025-01-17 | 2025-01-17 |
Pro-Dex Inc
(PDEX)
|
PS Planned sale |
CABILLOT RAYMOND E Non-Executive Director Large shareholder |
2,807
-0.8%
44.40USD 124,631 |
2,807 -0.8% | 44.40 | USD 124,631 | |
2025-01-17 | 2025-01-17 |
Lifeway Foods Inc
(LWAY)
|
S Sale |
SMOLYANSKY LUDMILA |
12,034
-1.2%
22.55USD 271,367 |
12,034 -1.2% | 22.55 | USD 271,367 | |
2025-01-17 | 2025-01-17 | PS Planned sale |
KATHWARI M FAROOQ Chairman, President & CEO Executive Director Large shareholder |
175
-0.7%
28.67USD 5,017 |
175 -0.7% | 28.67 | USD 5,017 | ||
2025-01-17 | 2025-01-17 | PS Planned sale |
KATHWARI M FAROOQ Chairman, President & CEO Executive Director Large shareholder |
175
-0.7%
28.67USD 5,017 |
175 -0.7% | 28.67 | USD 5,017 | ||
2025-01-17 | 2025-01-17 | PS Planned sale |
KATHWARI M FAROOQ Chairman, President & CEO Executive Director Large shareholder |
175
-0.7%
28.67USD 5,017 |
175 -0.7% | 28.67 | USD 5,017 | ||
2025-01-17 | 2025-01-17 | PS Planned sale |
KATHWARI M FAROOQ Chairman, President & CEO Executive Director Large shareholder |
175
-0.7%
28.67USD 5,017 |
175 -0.7% | 28.67 | USD 5,017 | ||
2025-01-17 | 2025-01-17 | PS Planned sale |
KATHWARI M FAROOQ Chairman, President & CEO Executive Director Large shareholder |
10,000
-0.6%
28.67USD 286,700 |
10,000 -0.6% | 28.67 | USD 286,700 | ||
2025-01-17 | 2025-01-17 |
OPKO Health Inc
(OPK)
|
B Purchase |
FROST PHILLIP MD ET AL CEO & Chairman Executive Director Large shareholder |
150,000
+0.1%
1.47USD 220,425 |
150,000 +0.1% | 1.47 | USD 220,425 | |
2025-01-17 | 2025-01-17 |
Expensify Inc
(EXFY)
|
PS Planned sale |
Barrett David Michael Chief Executive Officer Executive Director |
32,473
-1.5%
3.41USD 110,733 |
32,473 -1.5% | 3.41 | USD 110,733 | |
2025-01-17 | 2025-01-17 | B Purchase |
Little Harrison James Executive Vice President Officer |
5,000
+inf%
13.04USD 65,193 |
5,000 +inf% | 13.04 | USD 65,193 | ||
2025-01-17 | 2025-01-17 |
Aldel Financial Inc
(ADF)
|
PS Planned sale |
KAUFFMAN ROBERT I Non-Executive Director |
2,407
-0.1%
9.69USD 23,324 |
2,407 -0.1% | 9.69 | USD 23,324 | |
2025-01-17 | 2025-01-17 |
Barnwell Industries Inc
(BRN)
|
B Purchase |
Hopkins Craig Douglas Chief Executive Officer Officer |
10,000
+7.1%
1.65USD 16,500 |
10,000 +7.1% | 1.65 | USD 16,500 | |
2025-01-17 | 2025-01-17 |
Coinbase Global Inc
(COIN)
|
PS Planned sale |
HAAS ALESIA J Chief Financial Officer Officer |
20,000
-13.8%
300.00USD 6,000,000 |
20,000 -13.8% | 300.00 | USD 6,000,000 | |
2025-01-17 | 2025-01-17 | S Sale |
SRIVASTAVA SUDHIR Chairman and CEO Executive Director Large shareholder |
364,431
-0.4%
1.37USD 499,999 |
364,431 -0.4% | 1.37 | USD 499,999 | ||
2025-01-17 | 2025-01-17 |
Mackenzie Realty Capital Inc
(NONE)
|
B Purchase |
DIXON ROBERT E CEO/President Officer |
15,000
+75.2%
2.55USD 38,250 |
15,000 +75.2% | 2.55 | USD 38,250 | |
2025-01-17 | 2025-01-17 |
Anixa Biosciences Inc
(ANIX)
|
B Purchase |
Titterton Lewis H jr Non-Executive Director |
10,000
+1.1%
2.57USD 25,700 |
10,000 +1.1% | 2.57 | USD 25,700 | |
2025-01-17 | 2025-01-16 |
Quantum Corp
(QMCO)
|
S Sale |
Gianella Kenneth P. Chief Financial Officer Officer |
1,487
-4.2%
35.68USD 53,056 |
1,487 -4.2% | 35.68 | USD 53,056 | |
2025-01-17 | 2025-01-16 |
Quantum Corp
(QMCO)
|
S Sale |
Spanjaard Henk Jan Chief Revenue Officer Officer |
935
-5.9%
35.68USD 33,361 |
935 -5.9% | 35.68 | USD 33,361 | |
2025-01-17 | 2025-01-16 |
New York City REIT Inc
(NYCI)
|
B Purchase |
SCHORSCH NICHOLAS S Large shareholder |
1,367
+0.1%
9.08USD 12,412 |
1,367 +0.1% | 9.08 | USD 12,412 | |
2025-01-17 | 2025-01-16 |
Quantum Corp
(QMCO)
|
S Sale |
Cabrera Brian E SVP Chief Admin Ofcr & Secy Officer |
1,996
-6.7%
35.68USD 71,217 |
1,996 -6.7% | 35.68 | USD 71,217 | |
2025-01-17 | 2025-01-16 |
Quantum Corp
(QMCO)
|
S Sale |
Lerner James J President & CEO Executive Director |
2,511
-2.3%
35.68USD 89,592 |
2,511 -2.3% | 35.68 | USD 89,592 | |
2025-01-17 | 2025-01-16 |
Primeenergy Resources Corp
(PNRG)
|
S Sale |
HURT CLINT Non-Executive Director |
739
-0.6%
214.86USD 158,782 |
739 -0.6% | 214.86 | USD 158,782 |